ライフサイエンスコーパス: Beck depression inventory

1 Global Impression severity scale but not the Beck Depression Inventory.

2 eater severity of depression as shown by the Beck Depression Inventory.

3 the Hamilton Depression Rating Scale and the Beck Depression Inventory.

4 , Yale-Brown Obsessive Compulsive Scale, and Beck Depression Inventory.

5 epression scores as measured serially by the Beck Depression Inventory.

6 in depression symptoms as measured with the Beck Depression Inventory.

7 Survey along with Beck Anxiety Inventory and Beck Depression Inventory.

8 ed with General Health Questionnaire and the Beck Depression Inventory.

9 , the Hamilton Anxiety Rating Scale, and the Beck Depression Inventory.

10 e, and depressive symptom severity using the Beck Depression Inventory.

11 ne scores on the Brief Symptom Inventory and Beck Depression Inventory.

12 th self-report depression scales such as the Beck depression inventory (0.88, 0.42 to 1.33), and olde

13 ) the State-Trait Anxiety Inventory, (4) the Beck Depression Inventory-2, (5) and the Psychosocial Ad

14 n Rey Auditory Verbal Learning Test (RAVLT), Beck Depression Inventory-21 (BDI-21), and World Health

15 The prepandemic mean (SD) score of the Beck Depression Inventory (3.1 [2.8]) significantly incr

16 -10.8 to -3.2, d = -1.1, p = .0004) and the Beck Depression Inventory (-6.1 [2.6], 95% CI, -11.4 to

17 mptoms of depression were assessed using the Beck Depression Inventory administered at baseline, imme

18 , Montgomery-Asberg Depression Rating Scale, Beck Depression Inventory, Affective Pain Rating Index o

19 (mean age 56.4 +/- 1.3 years) completed the Beck Depression Inventory and a 15-min mild-graded exerc

20 The Beck Depression Inventory and Brief Symptom Inventory we

21 and several other instruments, including the Beck Depression Inventory and Brief Symptom Inventory.

22 BM reduced both measures of recurrence risk (Beck Depression Inventory and cortisol awakening respons

23 At entry and 6-week follow-up, the Beck Depression Inventory and Hamilton Depression Rating

24 es included ratings for depression symptoms (Beck Depression Inventory and Hamilton Depression Rating

25 e performed joint interaction testing of the Beck Depression Inventory and modified PTSD Symptom Scal

26 l advanced sleep phase accompanied by higher Beck Depression Inventory and seasonality scores.

27 dual depressive symptoms, measured using the Beck Depression Inventory and the cortisol awakening res

28 ts' self-reported behavior and affect on the Beck Depression Inventory and the Seasonal Pattern Asses

29 adiponectin levels), mood (assessed via the Beck Depression Inventory), and physical activity (asses

30 nes, depressive symptoms (assessed using the Beck Depression Inventory), and physical activity (asses

31 vent Questionnaire, Brief Symptom Inventory, Beck Depression Inventory, and Duke-UNC Functional Socia

32 rates, the Adverse Events Profile (AEP), the Beck Depression Inventory, and MINI Suicide Risk Module.

33 gnitive Assessment, semantic verbal fluency, Beck Depression Inventory, and Questionnaire for Impulsi

34 e measures were the Brief Symptom Inventory, Beck Depression Inventory, and Social Adjustment Scale.

35 1-item Hamilton Depression Rating Scale, the Beck Depression Inventory, and the Clinical Global Impre

36 he Edinburgh Postnatal Depression Scale, the Beck Depression Inventory, and the Hamilton Depression R

37 n, the Hamilton Depression Rating Scale, the Beck Depression Inventory, and the Perceived Stress Scal

38 e Yale-Brown Obsessive Compulsive Scale, the Beck Depression Inventory, and the Sickness Impact Profi

39 e Hospital Anxiety and Depression Score, the Beck Depression Inventory, and the State-Trait Anxiety I

40 elated with standard measures of depression (Beck Depression inventory), anxiety (Patient Related Anx

41 Stress Scale, and depressive symptoms by the Beck Depression Inventory at 8-year follow-up examinatio

42 te-Trait Anxiety Inventory), and depression (Beck Depression Inventory) at T3 were gender- and degree

43 trolled trial, 755 patients with depression (Beck Depression Inventory BDI-II score >/= 20) were recr

44 y wore an activity monitor and completed the Beck Depression Inventory (BDI) and 36-Item Short Form H

45 ndividuals with a score of 14 or more on the Beck depression inventory (BDI) and a confirmed diagnosi

46 Outcomes were measured using the Beck depression inventory (BDI) and a daily rating scale

47 ted using a validated Persian version of the Beck Depression Inventory (BDI) and Beck Anxiety Invento

48 Participants completed the Beck Depression Inventory (BDI) at ages 61.5 years (time

49 e assessed for depressive symptoms using the Beck Depression Inventory (BDI) at baseline and again 1

50 uspected coronary ischemia who completed the Beck Depression Inventory (BDI) at baseline and were fol

51 sive symptom severity was assessed using the Beck Depression Inventory (BDI) during hospitalization a

52 I) scale and symptoms of depression with the Beck Depression Inventory (BDI) scale in 291 patients wi

53 Fibromyalgia Impact Questionnaire (FIQ), the Beck Depression Inventory (BDI) scale, and visual analog

54 depressive symptomatology, as indicated by a Beck Depression Inventory (BDI) score > or = 10 (n = 47)

55 essed first with regression analyses against Beck Depression Inventory (BDI) scores in patients, and

56 The Beck Depression Inventory (BDI) scores of women who rece

57 urveys like the PTSD Symptom Scale (PSS) and Beck Depression Inventory (BDI) to indirectly assess a l

58 The Beck Depression Inventory (BDI) was administered to 11 p

59 ton rating scale for depression (Ham-D), the Beck depression inventory (BDI), and adverse events.

60 L-90), as well as the Short Form 36 (SF-36), Beck Depression Inventory (BDI), and one additional suic

61 r clinic completed the Short Form-36 and the Beck Depression Inventory (BDI), as well as suicide item

62 , depression severity was measured using the Beck Depression Inventory (BDI), female sexual function

63 Secondary measures included the Beck Depression Inventory (BDI), Hamilton Rating Scale f

64 ed; depressed mood was assessed by using the Beck Depression Inventory (BDI).

65 ilton Depression Rating Scale (HAM-D) and/or Beck Depression Inventory (BDI).

66 lton Rating Scale for Depression (HAM-D) and Beck Depression Inventory (BDI).

67 ing Scale motor subscale (MDS-UPDRS III) and Beck Depression Inventory (BDI).

68 ng with Heart Failure questionnaire, and the Beck Depression Inventory (BDI).

69 nts over placebo in at least one dose in the Beck Depression Inventory (BDI, P = 0.0143), Cognitive F

70 nal depressive symptoms were measured by the Beck Depression Inventory (BDI-II) at 26 weeks gestation

71 to the Geriatric Depression Scale (GDS) and Beck Depression Inventory (BDI; defined as a 50% reducti

72 eks and had substantial depressive symptoms (Beck Depression Inventory [BDI-II] score >/=14 and met I

73 pression (on antidepressants for >/=6 weeks, Beck depression inventory [BDI] score >/=14 and internat

74 Symptomatology-Self Report [QIDS-SR] or the Beck Depression Inventory [BDI]), obtained for up to 1 w

75 ed the standard Hungarian adaptations of the Beck Depression Inventory, Beck Anxiety Inventory, Spiel

76 tic interview schedule) and a questionnaire (Beck depression inventory) before discharge.

77 Top-ranked endophenotypes included the Beck Depression Inventory, bilateral ventral diencephalo

78 Outcomes included the Beck Depression Inventory, Center for Epidemiological St

79 The short form of the Beck Depression Inventory, completed at these same times

80 Scale, d = .53) and depressed mood severity (Beck Depression Inventory, d = .37) but not on the clini

81 Depressive symptoms as measured by the Beck Depression Inventory did not predict time to first

82 to 0.6] hours), mood (eg, mean difference in Beck Depression Inventory Fast Screen score, 0.2 [95% CI

83 The Beck Depression Inventory-Fast Screen and Beck Anxiety I

84 Depressive symptoms were assessed using the Beck Depression Inventory-Fast screen.

85 The Beck Depression Inventory for Youth (BDI-Y) assessed dep

86 gree of depression was measured by using the Beck Depression Inventory; glycemic control was measured

87 bal Learning Test, and mood ratings with the Beck Depression Inventory, Hamilton Depression Rating Sc

88 uropsychiatric symptoms were rated using the Beck Depression Inventory, Hospital Anxiety and Depressi

89 sessment, evaluation for depression with the Beck Depression Inventory II (BDI-II) and psychiatric in

90 RS and self-reported symptom severity on the Beck Depression Inventory II (BDI-II) at post treatment.

91 For this purpose and using the Beck Depression Inventory II (BDI-II) college students w

92 I to IV heart failure, and had completed the Beck Depression Inventory II (BDI-II) score were randomi

93 e Coping Strategies Questionnaire (CSQ), the Beck Depression Inventory II (BDI-II), and the McGill Pa

94 traditional neuropsychological tests and the Beck Depression Inventory II (BDI-II).

95 achieved significantly larger reductions in Beck Depression Inventory II (self-reported, P=0.03) and

96 nsultation, serum samples were taken and the Beck Depression Inventory II was completed to assess dep

97 nned use of health services (diaries), mood (Beck Depression Inventory II), and participation (Assess

98 Inventory), coexistent depressive symptoms (Beck Depression Inventory II), and physical/mental healt

99 s and 12 months with measures of depression (Beck Depression Inventory II), post-traumatic stress dis

100 ere assessed with the PTSD Checklist and the Beck Depression Inventory II, measured at baseline and a

101 d 2.9 points (95% CI, 1.1-4.9 points) on the Beck Depression Inventory II, respectively.

102 comorbidity);220(27.4%) had elevated BDI-II [Beck Depression Inventory II] scores (14), and 3 33(41.4

103 The Beck Depression Inventory-II (BDI), Beck Anxiety Invento

104 ires; depressive symptoms were measured with Beck Depression Inventory-II (BDI).

105 Primary outcomes were severity on the Beck Depression Inventory-II (BDI-II) and remission on t

106 CL-S); secondary measures were scores on the Beck Depression Inventory-II (BDI-II) and the Beck Scale

107 between depressive symptoms assessed by the Beck Depression Inventory-II (BDI-II) at baseline and af

108 e was a change in depression symptoms on the Beck Depression Inventory-II (BDI-II) over 12 weeks.

109 The primary outcome was the change in Beck Depression Inventory-II (BDI-II) score from baselin

110 xiety HADS score, depression HADS score, and Beck Depression Inventory-II (BDI-II) score.

111 Subjects were given the self-administered Beck Depression Inventory-II (BDI-II), National Eye Inst

112 We therefore prospectively employed the Beck Depression Inventory-II (BDI-II), the Hospital Anxi

113 icated Grief Inventory-Abbreviated (CGI) and Beck Depression Inventory-II (BDI-II).

114 d activities) on item-by-item examination of Beck Depression Inventory-II and Quick Inventory of Depr

115 ism, and Linguicism Subtests, along with the Beck Depression Inventory-II and the State and Trait Anx

116 Secondary outcome measures included the Beck Depression Inventory-II and the State-Trait Anger E

117 y outcomes included mood self-ratings on the Beck Depression Inventory-II and visual analogue mood sc

118 Scores on the self-administered Beck Depression Inventory-II at 3 months (primary) and 1

119 everity Scale (BFSS) score of 28 or greater, Beck Depression Inventory-II score less than 24, and no

120 tocol sample, a significant reduction of the Beck Depression Inventory-II scores 3 months following v

121 The mean change in Beck Depression Inventory-II scores after psychotherapy

122 The average change in Beck Depression Inventory-II scores due to treatment was

123 The Beck Depression Inventory-II was the most studied tool.

124 y (Brief Pain Inventory), and/or depression (Beck Depression Inventory-II) scores at 3 months.

125 averaging standardized scores of depression (Beck Depression Inventory-II), anxiety (State-Trait Anxi

126 depressive symptoms and remission (PHQ-9 and Beck Depression Inventory-II), generalised anxiety sympt

127 Depressive symptoms were measured with the Beck Depression Inventory-II, and cognitive symptoms wer

128 of depressive mood states examined using the Beck Depression Inventory-II, and general distress asses

129 ng and an assessment of depression using the Beck Depression Inventory-II, both obtained in the chron

130 hormone; psychological symptom inventories (Beck Depression Inventory-II, Brief Symptom Inventory-18

131 These were the Beck Depression Inventory-II, Brief Symptom Inventory-18

132 , 26 asymptomatic, 26 control) completed the Beck Depression Inventory-II, Profile of Mood States, an

133 onnaire (ISBQ), Burns Anxiety Inventory, the Beck Depression Inventory-II, the Hidradenitis Suppurati

134 pleted the Transgender Congruence Scale, the Beck Depression Inventory-II, the Revised Children's Man

135 ng functional magnetic resonance imaging and Beck Depression Inventory-II, were analyzed by intention

136 cohol Use Disorder Identification Test C and Beck Depression Inventory-II.

137 eck Anxiety Inventory], depressive symptoms [Beck Depression Inventory-II], and cognition [Montreal C

138 nal Pattern Assessment Questionnaire and the Beck Depression Inventory in Jining, China.

139 ty of depressive symptoms as assessed by the Beck depression inventory in MDD (n=14, r=0.55, P=0.042)

140 rsely associated with anhedonia items of the Beck Depression Inventory in particular.

141 ressed mood and anhedonia subscores from the Beck Depression Inventory in place of clinician intervie

142 variation, peripheral vascular disease, and Beck Depression Inventory independently correlated with

143 Beck Depression Inventory indicated more depression (p =

144 Principal components analyses (PCAs) of the Beck Depression Inventory items were conducted to examin

145 line, 0.51; mean follow-up, 2.63; P < .001), Beck Depression Inventory (mean baseline, 1.72; mean fol

146 4 months' follow-up and depressive symptoms (Beck Depression Inventory) measured at baseline, 2 month

147 ncluded four quality-of-life questionnaires (Beck Depression Inventory, Pittsburgh Sleep Quality Inde

148 erapy was associated with improved symptoms (Beck Depression Inventory pooled standardized mean diffe

149 s, follow-up data including results from the Beck Depression Inventory, Profile of Mood States, and S

150 ed an index of allergic inflammation and the Beck Depression Inventory provided an index of depressiv

151 PTSD Scale, Hamilton Scale for Anxiety, and Beck Depression Inventory, respectively.

152 The Beck Depression Inventory revealed an improvement of moo

153 The primary outcome measure was the Beck Depression Inventory Scale-version II (BDI-II) and

154 Psychiatric symptoms were assessed with the Beck Depression Inventory Scale.

155 patients achieving remission of depression (Beck Depression Inventory score < or = 9) was greater in

156 fect Scale score (P = .008), but not for the Beck Depression Inventory score (P = .29).

157 ociation between alcohol consumption and the Beck Depression Inventory score (r = 0.4; 95% CI, 0.2-0.

158 p r = 0.24; 95% CI, 0.16-0.31; patients with Beck Depression Inventory score of 28 or greater: bootst

159 oms were (partly) resolved (median change in Beck Depression Inventory score, -3 [IQR, -6 to 0]; P <

160 dicated that history of depression, baseline Beck Depression Inventory score, college education, and

161 as absence of MDD and at least 3 consecutive Beck Depression Inventory scores < 9) than SBFT (37.9%;

162 HRSD or having a less than 50% reduction in Beck Depression Inventory scores after 5 weeks.

163 gative symptoms had statistically equivalent Beck Depression Inventory scores and lifetime history of

164 Hamilton Depression Rating Scale and Beck Depression Inventory scores improved over the treat

165 itoring on several secondary outcomes (i.e., Beck Depression Inventory scores, anxiety, quality of li

166 9) after adjusting for history of stroke and Beck depression inventory scores.

167 rted history of depression treatment; and 3) Beck Depression Inventory scores.

168 depression severity on the SIGH-SAD and the Beck Depression Inventory-Second Edition (BDI-II), remis

169 Version (SIGH-SAD, administered weekly) and Beck Depression Inventory-Second Edition (BDI-II, admini

170 alpha = 0.81) and moderately correlates with Beck Depression Inventory-Second Edition (r = 0.293; p <

171 nistered along with a measure of depression (Beck Depression Inventory-Second Edition) to establish c

172 The study employed the Beck Depression Inventory Short Form, Stork Balance Test

173 k features; stress and mental health status (Beck Depression Inventory); sleep features (Insomnia Sev

174 d prediction scales (such as the Hamilton or Beck depression inventories), suicide prediction results

175 reductions in depression as measured on the Beck Depression Inventory than those in the mindfulness-

176 as assessed with the following measures: the Beck Depression Inventory, the Mental Health Inventory,

177 ients with scleroderma were administered the Beck Depression Inventory, the Neuroticism-Extraversion-

178 2v2 questionnaire and Persian version of the Beck Depression Inventory used to assess insomnia and po

179 omes were depression symptom severity on the Beck Depression Inventory version II and remission from

180 up had significantly lower symptom severity (Beck Depression Inventory version II in EUC plus HAP gro

181 The coprimary outcome measures were the Beck Depression Inventory (version 2) and the Maintenanc

182 [95% CI, -7.3 to -0.8]; P=0.02) lower on the Beck Depression Inventory, version 2 than those in the u

183 The Beck Depression Inventory was more generalisable across

184 omery-Asberg Depression Rating Scale and the Beck Depression Inventory were used to assess depressive

185 The Illness Effects Questionnaire and Beck Depression Inventory were used to evaluate quality

186 The Beck Depression Inventory, Young Mania Rating Scale, and